(Q36679440)

15 August 2017

1 reference

title

Rationale for intracoronary administration of abciximab (English)

1 reference

15 August 2017

0 references

Enrico Romagnoli

1

1 reference

15 August 2017

Francesco Burzotta

2

1 reference

15 August 2017

Carlo Trani

3

1 reference

15 August 2017

Giuseppe G L Biondi-Zoccai

4

1 reference

15 August 2017

Floriana Giannico

5

1 reference

15 August 2017

Filippo Crea

6

1 reference

15 August 2017

publication date

1 February 2007

1 reference

Journal of Thrombosis and Thrombolysis

15 August 2017

published in

1 reference

15 August 2017

volume

23

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

57-63

1 reference

https://scigraph.springernature.com/pub.10.1007/s11239-006-9000-0

15 August 2017

exact match

0 references

cites work

Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-9000-0

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-9000-0

Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-9000-0

7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-9000-0

Pathology of Acute and Chronic Coronary Stenting in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-9000-0

Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen

21 January 2018

1 reference

12 December 2020

Effects of abciximab and tirofiban on vitronectin receptors in human endothelial and smooth muscle cells.

1 reference

12 December 2020

Integrins: a family of cell surface receptors

1 reference

12 December 2020

The morphology of early atherosclerotic lesions of the aorta demonstrated by the surface technique in rabbits fed cholesterol; together with a description of the anatomy of the intima of the rabbit's aorta and the spontaneous lesions which occur in

1 reference

12 December 2020

Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty

1 reference

12 December 2020

Angioscopic evaluation of site-specific administration of ReoPro

1 reference

12 December 2020

Inhibition of platelet-mediated clot retraction by integrin antagonists

1 reference

12 December 2020

Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates

1 reference

12 December 2020

Platelet GPIIb-IIIa blockers

1 reference

12 December 2020

Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting

1 reference

12 December 2020

Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

1 reference

12 December 2020

Acute thrombotic occlusion of the left main coronary artery in a hypercoagulable patient treated with intracoronary abciximab

1 reference

12 December 2020

Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI

1 reference

12 December 2020

α v β 3 Integrin Expression in Normal and Atherosclerotic Artery

1 reference

12 December 2020

Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins

1 reference

12 December 2020

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

1 reference

12 December 2020

Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

12 December 2020

Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity

1 reference

12 December 2020

Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo

1 reference

12 December 2020

Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells

1 reference

12 December 2020

Primary angioplasty of an anomalous right coronary artery complicated by an acute thrombotic occlusion

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension

1 reference

12 December 2020

The beta3 integrin antagonist m7E3 reduces matrix metalloproteinase activity and smooth muscle cell migration

1 reference

12 December 2020

A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits

1 reference

12 December 2020

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group

1 reference

12 December 2020

A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1)

1 reference

12 December 2020

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

1 reference

12 December 2020

Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts

1 reference

12 December 2020

Role of integrin alpha(v)beta3 in vascular biology

1 reference

12 December 2020

Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: further evidence for smoldering inflammation in patients with atherosclerosis

1 reference

12 December 2020

Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.

1 reference

12 December 2020

Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.

1 reference

12 December 2020

Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen

1 reference

12 December 2020

Dissolution of thrombus formed during direct coronary angioplasty with a single 10 mg intracoronary bolus dose of abciximab

1 reference

12 December 2020

Immunofluorescent localization of adhesive glycoproteins in resting and thrombin-stimulated platelets

1 reference

12 December 2020

Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin

1 reference

12 December 2020

The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2).

1 reference

12 December 2020

An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates

1 reference

12 December 2020

Successful dissolution of occlusive coronary thrombus with local administration of abciximab during PTCA

1 reference

12 December 2020

c7E3Fab reduces postischemic leukocyte-thrombocyte interaction mediated by fibrinogen. Implications for myocardial reperfusion injury

1 reference

12 December 2020

Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation

1 reference

12 December 2020

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study

1 reference

12 December 2020

Pharmacodynamics of abciximab during angioplasty: comparison to healthy subjects

1 reference

12 December 2020

Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion

1 reference

12 December 2020

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

12 December 2020

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study

1 reference

12 December 2020

Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina

1 reference

12 December 2020

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

1 reference

12 December 2020

Binding of abciximab to alpha V beta 3 and activated alpha M beta 2 receptors: with a review of platelet-leukocyte interactions

1 reference

12 December 2020

Structure and function of leukocyte integrins

1 reference

12 December 2020

Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa

1 reference

12 December 2020

Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin

1 reference

12 December 2020

Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel

1 reference

12 December 2020

Use of abciximab prevents microcirculatory impairment in patients treated with coronary angioplasty for unstable angina: results of a prospective randomized study

1 reference

12 December 2020

Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction

1 reference

12 December 2020

Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade

1 reference

12 December 2020

10.1007/S11239-006-9000-0

Identifiers

DOI

1 reference

15 August 2017

1 reference